Full-Time
Join us to build the future of drug discovery
Confirmed live in the last 24 hours
AI-driven in vivo drug discovery platform
Junior
San Bruno, CA, USA
Vevo Therapeutics uses advanced AI models and its Mosaic platform to enhance drug discovery by generating high-resolution in vivo data, which studies drug interactions within living organisms. This method allows for the identification of new drug targets and candidates that traditional techniques might miss. The company serves pharmaceutical and biotech firms by providing insights into drug efficacy and gene expression at a single-cell level, making the drug discovery process faster and more cost-effective. Vevo's goal is to improve drug development, leading to better treatments for a broader range of patients.
Company Stage
Seed
Total Funding
$12M
Headquarters
San Francisco, California
Founded
2022